Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lars Ryden

Showing results (31-40 of 41) with videos related to

Pageof 5
Sort By:
Stroke|September 21, 2020
Rivaroxaban for Prevention of Covert Brain Infarcts and Cognitive Decline: The COMPASS MRI SubstudyMukul Sharma, Robert G Hart, Eric E Smith, et al.
International Journal of Stroke : Official Journal of the International Stroke Society|July 31, 2018
Rationale, design, and baseline participant characteristics in the MRI and cognitive substudy of the cardiovascular outcomes for people using anticoagulation strategies trialMukul Sharma, Robert G Hart, Eric E Smith, et al.
European Journal of Preventive Cardiology|August 12, 2025
International patterns in lipid management and implications for patients with coronary heart disease: results from the INTERASPIRE studyJulia Brandts, Fotios Barkas, Dirk De Bacquer, et al.
Global Heart|September 8, 2025
Cardiac Rehabilitation in Patients with Coronary Heart Disease - Provision, Attendance, and Outcomes: Results from the INTERASPIRE Survey from Fourteen Countries Across Six WHO RegionsKornelia Kotseva, Dirk De Bacquer, Catriona Jennings, et al.
Journal of the American College of Cardiology|May 28, 2025
Global Variation in Lipoprotein(a) Levels Among Patients With Coronary Heart Disease: Insights From the INTERASPIRE Study and Implications for Emerging Lp(a)-Lowering TherapiesFotios Barkas, Julia Brandts, Dirk De Bacquer, et al.
Gastroenterology|June 2, 2019
Safety of Proton Pump Inhibitors Based on a Large, Multi-Year, Randomized Trial of Patients Receiving Rivaroxaban or AspirinPaul Moayyedi, John W Eikelboom, Jackie Bosch, et al.
Gastroenterology|May 6, 2019
Pantoprazole to Prevent Gastroduodenal Events in Patients Receiving Rivaroxaban and/or Aspirin in a Randomized, Double-Blind, Placebo-Controlled TrialPaul Moayyedi, John W Eikelboom, Jackie Bosch, et al.
The New England Journal of Medicine|August 29, 2017
Rivaroxaban with or without Aspirin in Stable Cardiovascular DiseaseJohn W Eikelboom, Stuart J Connolly, Jackie Bosch, et al.
European Journal of Cardiovascular Prevention and Rehabilitation : Official Journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology|November 6, 2007
European guidelines on cardiovascular disease prevention in clinical practice: full text. Fourth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts)Ian Graham, Dan Atar, Knut Borch-Johnsen, et al.
The Canadian Journal of Cardiology|July 30, 2017
Rationale, Design and Baseline Characteristics of Participants in the Cardiovascular Outcomes for People Using Anticoagulation Strategies (COMPASS) TrialJackie Bosch, John W Eikelboom, Stuart J Connolly, et al.
Pageof 5

Showing results (31-40 of 41) with videos related to

Sort By:
Pageof 5
Stroke|September 21, 2020
Rivaroxaban for Prevention of Covert Brain Infarcts and Cognitive Decline: The COMPASS MRI SubstudyMukul Sharma, Robert G Hart, Eric E Smith, et al.
International Journal of Stroke : Official Journal of the International Stroke Society|July 31, 2018
Rationale, design, and baseline participant characteristics in the MRI and cognitive substudy of the cardiovascular outcomes for people using anticoagulation strategies trialMukul Sharma, Robert G Hart, Eric E Smith, et al.
European Journal of Preventive Cardiology|August 12, 2025
International patterns in lipid management and implications for patients with coronary heart disease: results from the INTERASPIRE studyJulia Brandts, Fotios Barkas, Dirk De Bacquer, et al.
Global Heart|September 8, 2025
Cardiac Rehabilitation in Patients with Coronary Heart Disease - Provision, Attendance, and Outcomes: Results from the INTERASPIRE Survey from Fourteen Countries Across Six WHO RegionsKornelia Kotseva, Dirk De Bacquer, Catriona Jennings, et al.
Journal of the American College of Cardiology|May 28, 2025
Global Variation in Lipoprotein(a) Levels Among Patients With Coronary Heart Disease: Insights From the INTERASPIRE Study and Implications for Emerging Lp(a)-Lowering TherapiesFotios Barkas, Julia Brandts, Dirk De Bacquer, et al.
Gastroenterology|June 2, 2019
Safety of Proton Pump Inhibitors Based on a Large, Multi-Year, Randomized Trial of Patients Receiving Rivaroxaban or AspirinPaul Moayyedi, John W Eikelboom, Jackie Bosch, et al.
Gastroenterology|May 6, 2019
Pantoprazole to Prevent Gastroduodenal Events in Patients Receiving Rivaroxaban and/or Aspirin in a Randomized, Double-Blind, Placebo-Controlled TrialPaul Moayyedi, John W Eikelboom, Jackie Bosch, et al.
The New England Journal of Medicine|August 29, 2017
Rivaroxaban with or without Aspirin in Stable Cardiovascular DiseaseJohn W Eikelboom, Stuart J Connolly, Jackie Bosch, et al.
European Journal of Cardiovascular Prevention and Rehabilitation : Official Journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology|November 6, 2007
European guidelines on cardiovascular disease prevention in clinical practice: full text. Fourth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts)Ian Graham, Dan Atar, Knut Borch-Johnsen, et al.
The Canadian Journal of Cardiology|July 30, 2017
Rationale, Design and Baseline Characteristics of Participants in the Cardiovascular Outcomes for People Using Anticoagulation Strategies (COMPASS) TrialJackie Bosch, John W Eikelboom, Stuart J Connolly, et al.
Pageof 5